Article info
PDFSystematic review
Systematic review of high-dose amikacin regimens for the treatment of Gram-negative infections based on EUCAST dosing recommendations
- Correspondence to Kevin J Frost, Airedale NHS Foundation Trust, Keighley BD20 6TD, UK; kevin.frost{at}nhs.net
Citation
Systematic review of high-dose amikacin regimens for the treatment of Gram-negative infections based on EUCAST dosing recommendations
Publication history
- Received June 10, 2022
- Accepted October 17, 2022
- First published November 7, 2022.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© European Association of Hospital Pharmacists 2022. No commercial re-use. See rights and permissions. Published by BMJ.